1. Home
  2. KURA vs VTLE Comparison

KURA vs VTLE Comparison

Compare KURA & VTLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • VTLE
  • Stock Information
  • Founded
  • KURA 2014
  • VTLE 2006
  • Country
  • KURA United States
  • VTLE United States
  • Employees
  • KURA N/A
  • VTLE N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • VTLE
  • Sector
  • KURA Health Care
  • VTLE
  • Exchange
  • KURA Nasdaq
  • VTLE Nasdaq
  • Market Cap
  • KURA 793.2M
  • VTLE 1.2B
  • IPO Year
  • KURA N/A
  • VTLE 2011
  • Fundamental
  • Price
  • KURA $7.26
  • VTLE $35.55
  • Analyst Decision
  • KURA Strong Buy
  • VTLE Hold
  • Analyst Count
  • KURA 11
  • VTLE 10
  • Target Price
  • KURA $27.89
  • VTLE $44.38
  • AVG Volume (30 Days)
  • KURA 1.8M
  • VTLE 853.4K
  • Earning Date
  • KURA 02-25-2025
  • VTLE 02-19-2025
  • Dividend Yield
  • KURA N/A
  • VTLE N/A
  • EPS Growth
  • KURA N/A
  • VTLE N/A
  • EPS
  • KURA N/A
  • VTLE 13.16
  • Revenue
  • KURA N/A
  • VTLE $1,862,465,000.00
  • Revenue This Year
  • KURA N/A
  • VTLE $29.36
  • Revenue Next Year
  • KURA $233.30
  • VTLE $7.49
  • P/E Ratio
  • KURA N/A
  • VTLE $2.70
  • Revenue Growth
  • KURA N/A
  • VTLE 26.94
  • 52 Week Low
  • KURA $6.98
  • VTLE $25.85
  • 52 Week High
  • KURA $24.17
  • VTLE $58.30
  • Technical
  • Relative Strength Index (RSI)
  • KURA 17.38
  • VTLE 72.80
  • Support Level
  • KURA $6.98
  • VTLE $27.93
  • Resistance Level
  • KURA $8.88
  • VTLE $36.35
  • Average True Range (ATR)
  • KURA 0.33
  • VTLE 1.01
  • MACD
  • KURA 0.05
  • VTLE 0.63
  • Stochastic Oscillator
  • KURA 13.40
  • VTLE 90.44

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

About VTLE Vital Energy Inc. par value $0.01 per share

Vital Energy is an independent energy company. Its business is focused on the acquisition, exploration, and development of oil and natural gas properties in the Permian Basin of West Texas. The Company has identified one operating segment: exploration and production.

Share on Social Networks: